The effect of antiplatelet drugs on the patency rate of arterio-venous fistulae in hemodialysis patients

Iranian Journal of Pharmaceutical Research

Volumn 9, Issue 4, 2010, Pages 451-457

  Rouzrokh, Mohsen ^a   Abbasi, Mohammad Reza ^b   Mirshemirani, Ali Reza ^c   Sobhiyeh, Mohammad Reza ^d  

^a SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Arterial venous fistulae; Aspirin; Dipyridamol; Patency rate

Indexed keywords

ACETYLSALICYLIC ACID; DIPYRIDAMOLE; PLACEBO;

ADULT; AGED; ARTERIOVENOUS FISTULA; ARTICLE; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; DRUG EFFECT; FEMALE; GASTROINTESTINAL HEMORRHAGE; HEMODIALYSIS PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; NAUSEA; NAUSEA AND VOMITING; RANDOMIZED CONTROLLED TRIAL; STOMACH PAIN; VASCULAR PATENCY;

EID: 78651256978     PISSN: 17350328     EISSN: 17266890     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Francis DM, Lu Y, Robertson AJ, Millar RJ and Amy J. Two stage brachiobasilica arteriovenous fistulae for chronic hemodialysis access. ANZ J. Surg. (2007) 77: 150-155.
2. Allon M, Robbin ML: Increasing arteriovenous fistulas in hemodialysis patients: Problems and solutions. Kidney Int. (2002) 62: 1109-1124.
3. Pastan S, Soucie JM, McClellan WM: Vascular access and increased risk of death among hemodialysis patients. Kidney Int. (2002) 62: 620-626.
4. Rooijens PPGM, Tordoir JHM, Stijnen T, et al. Radiocephalic wrist arteriovenous fistula for hemodialysis: meta-analysis indicates a high primary failure rate. Eur. J. Vasc. Endovasc. Surg. (2004) 28: 571-680.
5. Kherlakian GM, Roedersheimer LR, Arbaugh JJ, et al: Comparison of autogenous fistula versus expanded polytetrafluoroethylene graft fistula for angioaccess in hemodialysis. Am. J. Surg. (1986) 152: 238-24.
6. Van Hoek F, Scheltinga MR, Kouwenberg I, et al. Steal in hemodialysis patients depends on type of vascular access. Eur. J. Vasc. Endovasc. Surg. (2006) 32: 710-711.
7. Leitch R, Ouwendyk M, Ferguson E. Nursing issues related to patient selection, vascular access, and education in quotidian hemodialysis. Am. J. Kidney Dis. (2003) 42: 56-60.
8. Basile C, Casucci F, Lomonte C. Timing of first cannulation of arteriovenous fistula: time matters, but there is alsosomething else. Nephrol. Dial. Transplant. (2005) 20: 1519-1520.
9. Ascher E, Gade P, Hingorani A. Changes in the practice of angioaccess surgery: impact of dialysis outcome and quality initiative recommendations. J. Vasc. Surg. (2000) 31: 84-92.
10. Caplin N, Sedlacek M, Teodorescu V, Falk A, Uribarri J. Venous access: women are equal. Am. J. Kidney Dis. (2003) 41: 429-432.
11. Asif A, Roy-Chaudhury P, Beathard GA. Early arteriovenous fistula failure: a logical proposal for when and how to intervene. Clin. J. Am. Soc. Nephrol. (2006) 1: 332-339.
12. Wong V, Ward R, Taylor J, Selvakumar S, How TV, Bakran A. Factors associated with early failure of arteriovenous fistulae for haemodialysis access. Eur. J.Vasc. Endovasc. Surg. (1996) 12: 207-213.
13. Sreedhara R, Himmelfarb J, Lazarus JM, et al: Anti-platelet therapy in graft thrombosis: results of a prospective, randomized, double-blind study. Kidney Int. (1994) 45: 1477-1483.
14. Gaspari F, Vigano G, Orisio S: Aspirin prolongs bleeding time in uremia by a mechanism distinct from platelet cyclooxygenase inhibition. J. Clin. Invest. (1987) 79: 1788-1797.
15. De Abajo FJ, Garcia Rodriguez LA: Risk of upper gastrointestinal bleeding and perforation associated with low-dose aspirin as plain and enteric-coated formulations. BMC Clin. Pharmacol. (2001) 1: 1-2.
16. Livio M, Vigano G, Benigni A: Moderate doses of aspirin and risk of bleeding in renal failure. Lancet (1986) 1: 414-416.
17. Khan H, Jan H, Hafizullah M. study on clopidogrel in inhibition of platelet aggregation in suspected angina patients, treated with a daily dose of 75 mg of clopidogrel for 7 days. Iranian J. Pharm. Res. (2009) 8: 135-140.
18. Fahimi F, Baniasadi Sh, Behzadnia N, Varahram F, Ghazi Tabatabaie L. Enoxaparin utilization evaluation: an observational prospective study in medical inpatients. Iranian J. Pharm. Res. (2008) 7: 77-82.
19. Movahedian A, Sajjadi SE, Ahmadi M. Lipid lowering effect of ethanolic extract of aerial parts of Peucedanum pastinacifolium Boiss. and Hausskn in hypercholesterolemic rats. Iranian J. Pharm. Res. (2009) 8: 301-306.
20. Ortega T, Ortega F, Diaz-Corte C, et al. The timely construction of arteriovenous fistulae: a key to reducing morbidity and mortality and to improving cost management. Nephrol. Dial. Transplant. (2005) 20: 598-603.
21. Brimble KS, Rabbat ChG, Treleaven DJ, Ingram AJ. Utility of ultrasonographic venous assessment prior to forearm arteriovenous fistula creation. Clin. Nephrol. (2002) 58: 122-127.
22. Ravani P, Marcelli D, Malberti F. Vascular access surgery managed by renal physicians: the choice of native arteriovenous fistulas for hemodialysis. Am. J. Kidney Dis. (2002) 40: 1264-1276.
23. Ortega T, Ortega F, Diaz-Corte C, Rebollo P, Ma Vassalotti JA, Falk A, Cohl ED, et al. Obese and non-obese hemodialysis patients have a similar prevalence of functioning arteriovenous fistula using pre-operative vein mapping. Clinical. Nephrol. (2002) 58: 211-214.
24. Sedlacek M, Teodorescu V, Falk A, et al. Hemodialysis access placement with preoperative noninvasive vascular mapping: comparison between patients with and without diabetes. Am. J. Kidney Dis. (2001) 38: 560-564.
25. Silva MB Jr, Hobson RW 2nd, Pappas PJ, et al. A strategy for increasing use of autogenous hemodialysis access procedures: impact of preoperative noninvasive evaluation. J. Vasc. Surg. (1998) 27: 302-308.
26. Rus RR, Ponikvar R, Kenda RB, Buturovic-Ponikvar J. Effect of local physical training on the forearm arteries and veins in patients with end-stage renal disease. Blood Purif. (2003) 21: 389-39.
27. Brimble KS, Rabbat ChG, Treleaven DJ, et al. Utility of ultrasonographic venous assessment prior to forearm arteriovenous fistula creation. Clin. Nephrol. (2002) 58: 122-127.
28. Grontoft KC, Larsson R, Mulec H, Weiss LG, Dickinson JP: Effects of ticlopidine in AV-fistula surgery in uremia. Scand. J. Urol. Nephrol. (1998) 32: 276-283.
29. Kaufman JS: Antithrombotic agents and the prevention of access thrombosis. Semin. in Dial. (2000) 13: 40-46.
30. Hasegawa T, Elder SJ, Bragg-gresham JL. Consistent aspirin use associated with improved AVF survival among incident hemodialysis patients in the dialysis outcomes and practice patterns study. Clin. J. Am. Soc. Nephrol. (2008) 3: 1373-1378.
31. Yevzlin AS, Conley EL and Sanchez RJ. Vascular access outcomes and medication use: A USRDS study. Semin. Dial. (2006) 19: 535-539.